Inflammatory cytokines in major surgery: a functional perspective
暂无分享,去创建一个
[1] G. Wanner,et al. Mixed agonistic-antagonistic cytokine response in whole blood from patients undergoing abdominal aortic aneurysm repair , 1999, Intensive Care Medicine.
[2] S. Garg,et al. Exogenous interleukin-10 fails to decrease the mortality or morbidity of sepsis. , 1998, Critical care medicine.
[3] J. Nick,et al. p38 Mitogen-activated Protein Kinase-dependent and -independent Intracellular Signal Transduction Pathways Leading to Apoptosis in Human Neutrophils* , 1998, The Journal of Biological Chemistry.
[4] M. Jordana,et al. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. , 1998, The Journal of clinical investigation.
[5] J. Marshall,et al. Dysregulated expression of neutrophil apoptosis in the systemic inflammatory response syndrome. , 1997, Archives of surgery.
[6] J. Lederer,et al. Major injury induces increased production of interleukin-10 by cells of the immune system with a negative impact on resistance to infection. , 1997, Annals of surgery.
[7] D. Männel,et al. Role of NFkappaB in the mortality of sepsis. , 1997, The Journal of clinical investigation.
[8] S. Ashley,et al. Interleukin-10 prevents early cytokine release in severe intraabdominal infection and sepsis. , 1997, The Journal of surgical research.
[9] J. Reynolds,et al. Interleukin-10. A role in the development of postoperative immunosuppression. , 1997 .
[10] C. Miki,et al. Influence of intraoperative blood loss on plasma levels of cytokines and endotoxin and subsequent graft liver function. , 1997, Archives of surgery.
[11] E. Moore,et al. Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation? , 1996, Annals of surgery.
[12] J. Bland,et al. Plasma proinflammatory cytokine concentrations, Acute Physiology and Chronic Health Evaluation (APACHE) III scores and survival in patients in an intensive care unit. , 1996, Critical care medicine.
[13] R. Bone,et al. Sir Isaac Newton, sepsis, SIRS, and CARS. , 1996, Critical care medicine.
[14] S. Lowry,et al. Biologic Control of Injury and Inflammation: Much More than Too Little or Too Late , 1996, World Journal of Surgery.
[15] P. Barie,et al. Monocyte tumor necrosis factor receptor levels as a predictor of risk in human sepsis. , 1996, Archives of surgery.
[16] T. van der Poll,et al. Endogenous IL-10 protects mice from death during septic peritonitis. , 1995, Journal of immunology.
[17] C. Sprung,et al. Multiple organ dysfunction score: a reliable descriptor of a complex clinical outcome. , 1995, Critical care medicine.
[18] D. Kwiatkowski,et al. Systemic cytokine response after major surgery , 1992, The British journal of surgery.
[19] W. Knaus,et al. The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. , 1991, Chest.
[20] W. Fraser,et al. Response of serum interleukin-6 in patients undergoing elective surgery of varying severity. , 1990, Clinical science.
[21] L. Moldawer,et al. The biologic characteristics of cytokines and their implication in surgical injury. , 1990, Surgery, gynecology & obstetrics.
[22] T. Ikejima,et al. Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition. , 1988, The Journal of clinical investigation.
[23] J. D. Albert,et al. Shock and tissue injury induced by recombinant human cachectin. , 1986, Science.
[24] W. Knaus,et al. APACHE II: a severity of disease classification system. , 1985 .
[25] OLAND,et al. TREATMENT OF SEPTIC SHOCK WITH THE TUMOR NECROSIS FACTOR RECEPTOR : Fc FUSION PROTEIN C , 2000 .
[26] E. Moore,et al. Interleukin-6 delays neutrophil apoptosis. , 1996, Archives of surgery.
[27] H. Tilg,et al. Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. , 1994, Blood.
[28] C. Dinarello,et al. Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. , 1990, Blood.